Analytics in the past couple years have moved far beyond the simple dashboards used by many cardiology department administrators to dedicated, complex, powerful data mining and interpretation software. Patient data is increasingly concentrated in the electronic medical record (EMR). More data is now collected by the diagnostic testing systems and imaging equipment. Department, hospital and healthcare system data on billing, patient throughput, scheduling, inventory and expenses are tallied electronically. These data offer new tools for department directors to improve efficiency. 


IBA Molecular has successfully completed its acquisition of Mallinckrodt Nuclear Imaging, announced in August 2016, following the receipt of regulatory approvals.

DAIC has worked hard to bring useful technology news and resources to our readers. While we conduct reader surveys and speak to readers at site visits and conferences, one of the clearest views we have of reader interests is based on what they are reading on our website, e-newsletters and digital editions. We have responded to these analytics in what we publish and how we cover new cardiovascular technology. The result has been a big increase in our online readership over the past year. For the first time, DAIC’s website broke 1 million pageviews in November 2016.

HyperMed Imaging Inc. announced that it has received clearance from the U.S. Food and Drug Administration (FDA) for the company’s new medical imaging device called HyperView. The HyperView product is a handheld, battery operated, portable diagnostic imaging device that is used to assess tissue oxygenation without contacting the patient.  The product is intended for use by physicians and healthcare professionals as a noninvasive tissue oxygenation measurement system that reports an approximate value of oxygen saturation (O2Sat), oxyhemoglobin level (Oxy) and deoxyhemoglobin level (Deoxy) in superficial tissue.

Researchers at Binghamton University, State University of New York have devised a new way to protect personal electronic health records using a patient’s own heartbeat.

For the first time, researchers have developed tests that could improve treatment for heart failure patients by diagnosing the condition with greater accuracy and detecting the onset of congestive heart failure earlier. The findings were published in the Cardiovascular Disease issue of Clinical Chemistry, the journal of the American Association for Clinical Chemistry (AACC).

The ultrasound systems space, which covers 39 major markets, is set to rise steadily from $4.2 billion in 2016 to $5 billion by 2023, according to research and consulting firm GlobalData. This represents a compound annual growth rate (CAGR) of 2.5 percent. The company’s latest report states that the growth will primarily be driven by the rising prevalence of diseases and expanding demand for cost-effective quality healthcare.

People with any form of diabetes are at greater risk of developing cardiovascular conditions than people without the disease. Moreover, if they undergo an operation to open up a clogged artery by inserting a stent, the artery is much more likely to clog up again. However, researchers at Joslin Diabetes Centers, Boston, now have uncovered an explanation for why these procedures often fail, which may lead toward better alternatives.

Subscribe Now